GLP-1受体激动因子相关的瘦身者:对外围神经外科医生的影响
Pooja Dhupati1, Sara C Kisiel1, Krishna Unadkat2
1From the University of Arizona College of Medicine-Phoenix, Phoenix.
Annals of plastic surgery
|December 19, 2025
概括
类似葡萄糖-1受体激动剂 (GLP-1RAs) 可以导致"瘦身麻",一种神经并发症. 早期识别和干预对于那些在这些流行的药物上快速减肥的患者至关重要.
科学领域:
- 神经学 神经学
- 内分泌学 在内分泌学.
- 代谢健康 代谢健康
背景情况:
- 类似葡萄糖-1受体激动剂 (GLP-1RAs) 广泛用于体重管理和心脏代谢健康.
- 快速减肥可以导致脂肪组织减少,导致神经压缩,特别常见的神经病变 (CPN) 在骨头,一种被称为"瘦身者"的疾病.
- 尽管与其他快速减肥场景相关联,但斯利默氏仍然被认为是GLP-1RA治疗的并发症.
研究的目的:
- 在使用GLP-1RAs减肥的患者中报告急性落脚 (CPN) 的病例.
- 为了突出Slimmer的麻作为GLP-1RA治疗的潜在并发症.
- 提高外围神经外科医生对这种可预测的并发症的认识.
主要方法:
- 两名非糖尿病患者的病例报告.
- 详细的病史,包括减肥的百分比和持续时间.
- 药物审查侧重于GLP-1RA的使用 (塞马格卢提德和蒂尔泽帕提德).
主要成果:
- 两名患者在接受GLP-1RA治疗3-6个月后,体重下降了14%和18%,出现了急性脚.
- CPN的发作暂时与semaglutide和tirzepatide诱导的显著,快速的体重减轻有关.
- 这些发现表明GLP-1RA诱导的体重减轻和Slimmer's Palsy的发展之间存在联系.
结论:
- 斯利默氏是一种与GLP-1RA使用相关的快速减肥的可预测并发症.
- 周围神经外科医生必须意识到这种情况,以确保及时诊断和干预.
- 早期干预可以预防永久性皮肤脱皮,并改善患者的治疗结果.
相关概念视频
Peripheral Artery Disease V: Postoperative Nursing Management
354
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
354
Local Anesthetics: Differential Sensitivity of Nerve Fibers
1.3K
Local anesthetics (LAs) block the sodium channels of nerve trunks, sensory nerve endings, and neuromuscular junctions. Although LAs can block all kinds of nerves, the sensitivity of nerve fibers differs according to nerve types and structures. LAs are known to block myelinated fibers faster than unmyelinated ones. Also, they block pain or sensory neurons at low concentrations without affecting the motor neurons involved in muscle contractions. This helps relieve labor pain without affecting the...
1.3K


